Literature DB >> 28040391

Light induced drug release from a folic acid-drug conjugate.

M Michael Dcona1, Jonathon E Sheldon2, Deboleena Mitra2, Matthew C T Hartman3.   

Abstract

A major area of cancer research focuses on improving the specificity of therapeutic agents by engineering drug-delivery vehicles that target overexpressed receptors on tumor cells. One of the most commonly used approaches involves targeting of folate receptors using folic acid conjugated to a drug-containing macromolecular cargo. Once internalized via endocytosis, the drugs must be released from these constructs in order to avoid being trapped in the endosomes. Here, we describe the synthesis of a small-molecule conjugate that couples folic acid to doxorubicin via a photocleavable linker. Using HPLC we show that the doxorubicin can be released with light rapidly and with high efficiency. This approach has advantages over macromolecular systems due to its simplicity and efficiency.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug release; Endosomal entrapment; Folic acid; HPLC; Photocage

Mesh:

Substances:

Year:  2016        PMID: 28040391      PMCID: PMC5267943          DOI: 10.1016/j.bmcl.2016.12.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  42 in total

Review 1.  Engineering folate-drug conjugates to target cancer: from chemistry to clinic.

Authors:  Iontcho R Vlahov; Christopher P Leamon
Journal:  Bioconjug Chem       Date:  2012-06-26       Impact factor: 4.774

2.  Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate.

Authors:  Seok Ki Choi; Thommey Thomas; Ming-Hsin Li; Alina Kotlyar; Ankur Desai; James R Baker
Journal:  Chem Commun (Camb)       Date:  2010-02-06       Impact factor: 6.222

Review 3.  Oncologic photodynamic therapy photosensitizers: a clinical review.

Authors:  Ron R Allison; Claudio H Sibata
Journal:  Photodiagnosis Photodyn Ther       Date:  2010-04-21       Impact factor: 3.631

4.  Near-infrared light photocontrolled targeting, bioimaging, and chemotherapy with caged upconversion nanoparticles in vitro and in vivo.

Authors:  Yi-Hsin Chien; Yu-Lin Chou; Shu-Wen Wang; Shu-Ting Hung; Min-Chiau Liau; Yu-Jo Chao; Chia-Hao Su; Chen-Sheng Yeh
Journal:  ACS Nano       Date:  2013-09-30       Impact factor: 15.881

Review 5.  Ultraviolet light-mediated drug delivery: Principles, applications, and challenges.

Authors:  Aoune Barhoumi; Qian Liu; Daniel S Kohane
Journal:  J Control Release       Date:  2015-07-21       Impact factor: 9.776

Review 6.  The epidermal growth factor receptor pathway: a model for targeted therapy.

Authors:  Maurizio Scaltriti; José Baselga
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

7.  meso-Methylhydroxy BODIPY: a scaffold for photo-labile protecting groups.

Authors:  Naama Rubinstein; Pei Liu; Evan W Miller; Roy Weinstain
Journal:  Chem Commun (Camb)       Date:  2015-04-14       Impact factor: 6.222

8.  Photoresponsive nanoparticles for drug delivery.

Authors:  Alina Y Rwei; Weiping Wang; Daniel S Kohane
Journal:  Nano Today       Date:  2015-07-15       Impact factor: 20.722

9.  Photoswitchable anticancer activity via trans-cis isomerization of a combretastatin A-4 analog.

Authors:  Jonathon E Sheldon; M Michael Dcona; Charles E Lyons; John C Hackett; Matthew C T Hartman
Journal:  Org Biomol Chem       Date:  2015-10-27       Impact factor: 3.876

10.  Photoactivatable Prodrugs of Antimelanoma Agent Vemurafenib.

Authors:  Rebecca Horbert; Boris Pinchuk; Paul Davies; Dario Alessi; Christian Peifer
Journal:  ACS Chem Biol       Date:  2015-07-10       Impact factor: 5.100

View more
  1 in total

Review 1.  Advances in targeting the folate receptor in the treatment/imaging of cancers.

Authors:  Marcos Fernández; Faiza Javaid; Vijay Chudasama
Journal:  Chem Sci       Date:  2017-12-18       Impact factor: 9.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.